The 5-year CSS and DFS rates for patients in the high LDLRAD4 protein expression group were 83.1% and 75.9%, respectively, compared with 65.6% and 59.7% in CRC patients in the low LDLRAD4 protein expression group (p = 0.022, Fig. 3k; p = 0.033, Fig. 3l). Here, LDLRAD4 is linked to colorectal carcinoma.